Month: June 2023
Acalabrutinib-Containing Regimens Show Superior Progression-Free Survival in Elevate-TN Trial for Chronic Lymphocytic Leukemia
The results of the Elevate-TN trial, a phase 3 clinical trial evaluating the efficacy of acalabrutinib-containing regimens in patients with chronic lymphocytic leukemia (CLL), have…
June – A Month to Celebrate Cancer Survivorship
June is a month of commemoration and appreciation for the indomitable spirit of those who have triumphed over cancer. Cancer Survivor Month provides an opportunity…